Suzanne Dahlberg (@suzdahlberg) 's Twitter Profile
Suzanne Dahlberg

@suzdahlberg

Biostatistician @BostonChildrens | Assoc. Professor @HarvardMed | Bostonian | Tweets & opinions are my own.

ID: 928994577670922240

calendar_today10-11-2017 14:35:42

484 Tweet

388 Followers

337 Following

Suzanne Dahlberg (@suzdahlberg) 's Twitter Profile Photo

Oppositely, when grant applicants write their own stats stating they'll use "Kaplan Mayer," I suspect they've not studied it. (And it makes me think of the Oscar Mayer bologna jingle: "And if you ask me why I'll say, 'Cause Kaplan-Meier has a way with l-o-g-r-a-n-k.")

Christine Lovly, MD, PhD, FASCO (@christine_lovly) 's Twitter Profile Photo

ā¬‡ļøMore innovative research from the amazing Elsa Anagnostou! #LCSM @oncoalert Nature Medicine Johns Hopkins Thoracic Oncology Researchers Johns Hopkins Kimmel Cancer Center find persistant mutations not edited out in cancer make tumors more responsive to #immunotherapy. hopkinsmedicine.org/news/newsroom/… via Hopkins Med News

Suzanne Dahlberg (@suzdahlberg) 's Twitter Profile Photo

When I see results like this my first thought is: is that longer than 1 scan interval? Bc the drug could extend PFS by only 1 day but you’re still not gonna capture that ā€œdelayedā€ progression until the next disease assessment, weeks later.

Drew Moghanaki (@drewmoghanaki) 's Twitter Profile Photo

The LUNGevity Foundation is cultivating future lung cancer scientists through EIGHT PROGRAMS. Apply here: lungevity.org/research/trans…

The LUNGevity Foundation is cultivating future lung cancer scientists through EIGHT PROGRAMS. Apply here: lungevity.org/research/trans…
Sameer Parpia (@parpiasameer) 's Twitter Profile Photo

Application for the CANSTAT Clinical Trial Biostatistics Fellowship Program is Open. Apply at can-stat.ca #clinicaltrials #biostatistics

Application for the CANSTAT Clinical Trial Biostatistics Fellowship Program is Open. Apply at can-stat.ca #clinicaltrials #biostatistics
Pippa Cosper MD, PhD (@pipcosper) 's Twitter Profile Photo

Oh lord. Out of 755 oncology phase 3 RCT trials, 20% changed their primary endpoint after the study started. This was associated with trial positivity (!!) and 70% of these did not disclose these changes in the manuscript. What are we doing here??? 😵 jamanetwork.com/journals/jaman…

UAB School of Public Health (@uabsoph) 's Twitter Profile Photo

The Chronic Hypertension and Pregnancy (CHAP) trial received the David Sackett Trial of the Year award by SCTorg; results were presented today at #SCT2023. Dr. Szychowski, prof. of UAB SOPH Department of Biostatistics, is PI for CHAP's Data Coordinating Center. Read more here: uab.edu/news/research/…

Suzanne Dahlberg (@suzdahlberg) 's Twitter Profile Photo

It was an honor today to present the SCTorg Trial of the Year award to Dr. Alan Tita, PI of the CHAP Trial. Congratulations to him & the study team on this incredibly well-deserved recognition for their transformative work. @UAB_CWRH UAB SOPH Department of Biostatistics #SCT2023 tinyurl.com/54nhmnp9

Bernard A Fox (@bernardafox) 's Twitter Profile Photo

1) Dr Suzanne Dahlberg biostatistician Boston Children's & Harvard Medical School gives a great critique of David Gandara & Dr Megan Othus presentations/ #TMB as a predictive #biomarker of response to immune #checkpoint tx /Impact of dichotomizing #cancer #immunotherapy #ASCO2023 #ASCO23

1) Dr <a href="/SuzDahlberg/">Suzanne Dahlberg</a> biostatistician <a href="/BostonChildrens/">Boston Children's</a> &amp; <a href="/harvardmed/">Harvard Medical School</a> gives a great critique of <a href="/drgandara/">David Gandara</a> &amp; Dr Megan Othus presentations/ #TMB as a predictive #biomarker of response to immune #checkpoint tx /Impact of dichotomizing #cancer #immunotherapy #ASCO2023 #ASCO23
Kelly Fitzgerald (@kellynfitz) 's Twitter Profile Photo

Interesting data presented/discussed by statisticians SWOG Cancer Research Network #MeganOthus and Boston Children's #SuzanneDahlberg showing that not all RECIST PRs are created equal - supports exploration of depth of response as a prognostic biomarker in RCC by #cristinasuarez and others

Interesting data presented/discussed by statisticians <a href="/SWOG/">SWOG Cancer Research Network</a> #MeganOthus and <a href="/BostonChildrens/">Boston Children's</a> #SuzanneDahlberg showing that not all RECIST PRs are created equal - supports exploration of depth of response as a prognostic biomarker in RCC by #cristinasuarez and others
Suzanne Dahlberg (@suzdahlberg) 's Twitter Profile Photo

šŸ‘‡šŸ»šŸ‘‡šŸ»šŸ‘‡šŸ» I am psyched to have met my ASCO Virtual Mentoring Program mentee Khaoula Ben Haj Frej in real life. She’s a future star researcher in the making! #ASCO23

UAB Heersink School of Medicine (@uabheersink) 's Twitter Profile Photo

The #CHAP trial was named a Notable Article of 2022 by NEJM and the David Sackett Trial of the Year by SCTorg. Alan T N Tita, MD, PhD and the #CHAP team also received a 2023 Top Ten Clinical Research Achievement Award from Clinical Research Forum. Ā  More:Ā go.uab.edu/chaptrialofthe… AAMC UAB

Adam Grant (@adammgrant) 's Twitter Profile Photo

When you burn people out, you push them out. Stars are the first to leave—they have the most opportunities. The solution is not to pile on the perks. It’s to pinpoint the root causes of overload and design more manageable jobs. If you want to keep people, stop exhausting them.

When you burn people out, you push them out. Stars are the first to leave—they have the most opportunities.

The solution is not to pile on the perks. It’s to pinpoint the root causes of overload and design more manageable jobs.

If you want to keep people, stop exhausting them.